Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy

Bina Shah, Emily Breidbart, Melissa Pawelczak, Leslie Lam, Marion Kessler, Bonita Franklin

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Background: Activating mutations of the ABCC8 gene can lead to permanent neonatal diabetes mellitus (PNDM). Glucose variability in infants with NDM treated with insulin can be extreme. We report long-term glycemic control in a patient with PNDM on sulfonylurea therapy, despite initial allergic reaction. Methods: A Chinese girl presented on the first day of life with persistent hyperglycemia. Despite treatment with various insulin regimens, hemoglobin (Hb) A1c (normal 4.8%-6.3%) increased from 5.0% at 14 days of age to a peak of 9.7% at 15 months of age. Her average insulin dose was 0.5 units/kg/day. Genetic analysis revealed two novel ABCC8 gene activating mutations encoding the β-cell sulfonylurea-1 receptor of the ATP-sensitive potassium channel. At age 3 years 2 months, transition from insulin to the oral sulfonylurea glyburide was initiated. After 8 days, she developed urticaria, palmar erythema, and a diffuse maculopapular rash, which resolved when medication was discontinued. At age 3 years 11 months, glyburide was reintroduced at a very low dose and was increased with concomitant weaning of insulin over the following 6 months. Results: Normoglycemia (HbA 1c 5.6%) was achieved on glyburide without any further allergic reaction at the age of 4 years 5 months with improved metabolic control. For the next 3 years, HbA 1c measurements, and glucose means and variability were significantly lower compared with values during insulin therapy. Conclusions: As compared with subcutaneous insulin, oral sulfonylureas improved long-term metabolic control in a patient with NDM caused by novel activating mutations in the ABCC8 gene. Desensitization permitted safe oral sulfonylurea therapy in our patient with NDM despite initial allergic reaction. Fewer episodes of hypoglycemia occurred on sulfonylurea than on insulin therapy, which is an advantage in a very young child.

Original languageEnglish (US)
Pages (from-to)353-356
Number of pages4
JournalJournal of Pediatric Endocrinology and Metabolism
Issue number3-4
StatePublished - Apr 1 2012
Externally publishedYes


  • neonatal diabetes
  • sulfonylurea

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy'. Together they form a unique fingerprint.

Cite this